Epidemiology and Outcomes

Association of one-point glucocorticoid-free status with chronic damage and disease duration in systemic lupus erythematosus: a cross-sectional study

Ken-ei Sada, Yu Katayama, Yosuke Asano, Keigo Hayashi, Yoshia Miyawaki, Keiji Ohashi, Eri Katsuyama, Takayuki Katsuyama, Mariko Takano-Narazaki, Yoshinori Matsumoto, Ryusuke Yoshimi, Yasuhiro Shimojima, Shigeru Ohno, Hiroshi Kajiyama, Kunihiro Ichinose, Shuzo Sato, Michio Fujiwara, Nobuyuki Yajima

10.1136/lupus-2022-000772

September 27, 2022

Adverse pregnancy outcomes in women with systemic lupus erythematosus: can we improve predictions with machine learning?

Melissa J Fazzari, Marta M Guerra, Jane Salmon, Mimi Y Kim

10.1136/lupus-2022-000769

September 14, 2022

Generation of evidence supporting the content validity of SF-36, FACIT-F, and LupusQoL, and novel patient-reported symptom items for use in patients with systemic lupus erythematosus (SLE) and SLE with lupus nephritis (LN)

Rebecca Williams-Hall, Pamela Berry, Nicola Williamson, Melissa Barclay, Anna Roberts, Adam Gater, Chloe Tolley, Helena Bradley, Amy Ward, Elizabeth Hsia, Qing Zuraw, Patricia DeLong, Zahi Touma, Vibeke Strand

10.1136/lupus-2022-000712

August 25, 2022

Medium-term impact of the SARS-CoV-2 mRNA vaccine against disease activity in patients with systemic lupus erythematosus

Tsuneyasu Yoshida, Hideaki Tsuji, Akira Onishi, Yudai Takase, Mirei Shirakashi, Hideo Onizawa, Ryosuke Hiwa, Koji Kitagori, Shuji Akizuki, Ran Nakashima, Masao Tanaka, Hajime Yoshifuji, Akio Morinobu

10.1136/lupus-2022-000727

August 12, 2022

Intermittent and Persistent Type 2 lupus: patient perspectives on two distinct patterns of Type 2 SLE symptoms

Amanda M Eudy, Jennifer L Rogers, Amy Corneli, Kevin McKenna, Mithu Maheswaranathan, David S Pisetsky, Lisa G Criscione-Schreiber, Jayanth Doss, Rebecca E Sadun, Kai Sun, Megan E B Clowse

10.1136/lupus-2022-000705

August 5, 2022

Patient and healthcare team recommended medication adherence strategies for hydroxychloroquine: results of a qualitative study informing intervention development

Shivani Garg, Betty Chewning, David Gazeley, Shelby Gomez, Noah Kaitz, Amanda C Weber, Ann Rosenthal, Christie Bartels

10.1136/lupus-2022-000720

August 1, 2022

Immunogenicity of the third and fourth BNT162b2 mRNA COVID-19 boosters and factors associated with immune response in patients with SLE and rheumatoid arthritis

Theerada Assawasaksakul, Seelwan Sathitratanacheewin, Preeyaporn Vichaiwattana, Nasamon Wanlapakorn, Yong Poovorawan, Yingyos Avihingsanon, Nawaporn Assawasaksakul, Wonngarm Kittanamongkolchai

10.1136/lupus-2022-000726

July 28, 2022

Social Factors, Epigenomics and Lupus in African American Women (SELA) Study: protocol for an observational mechanistic study examining the interplay of multiple individual and social factors on lupus outcomes in a health disparity population

Emily L Vara, Carl D Langefeld, Bethany J Wolf, Timothy D Howard, Gregory A Hawkins, Queen Quet, Lee H Moultrie, L Quinnette King, Ivan D Molano, Stephanie L Bray, Lori Ann Ueberroth, S Sam Lim, Edith M Williams, Diane L Kamen, Paula S Ramos

10.1136/lupus-2022-000698

June 29, 2022

Impact of low-dose acetylsalicylic acid on pregnancy outcome in systemic lupus erythematosus: results from a multicentre study

Chiara Tani, Dina Zucchi, Isabell Haase, Maria Gerosa, Maddalena Larosa, Lorenzo Cavagna, Alessandra Bortoluzzi, Francesca Crisafulli, Johanna Mucke, Francesca A L Strigini, Laura Baglietto, Marco Fornili, Francesca Monacci, Elena Elefante, Roberta Erra, Elisa Bellis, Melissa Padovan, Laura Andreoli, Lavinia Agra Coletto, Giovanni Zanframundo, Marcello Govoni, Luca Iaccarino, Angela Tincani, Andrea Doria, Rebecca Fischer-Betz, Marta Mosca

10.1136/lupus-2022-000714

June 14, 2022

Glucocorticoid discontinuation in patients with SLE with prior severe organ involvement: a single-center retrospective analysis

Takehiro Nakai, Sho Fukui, Yukihiko Ikeda, Masei Suda, Hiromichi Tamaki, Masato Okada

10.1136/lupus-2022-000682

June 2, 2022